BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Max Healthcare Institute Ltd. Share Price

NSE
BSE

NSE : MAXHEALTH

BSE : 543220

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹1,094.00

High

₹1,132.00

Price Summary

Previous Close ₹1,095.90
Day's Range ₹1,094.00 - ₹1,132.00
Open ₹1,119.70
52 Week Range ₹903.00 - ₹1,310.80
Volume 8,30,861
Market Cap ₹0.11
Previous Close ₹1,095.10
Day's Range ₹1,094.35 - ₹1,128.25
Open ₹1,115.25
52 Week Range ₹903.50 - ₹1,310.90
Volume 56,347
Market Cap ₹0.11

Stocks Summary

Trade Value ( ₹ in Lacs) 9,105.41
Market Cap (₹ in Mn) 0.11
Dividend Yield(%) 0.18
Price/Earning (TTM) 75.56
TTM EPS (₹) 14.82
P/E Ratio 99.10
Book Value(₹) 10.14
PAT Margin (%) 15.31
Face Value (₹) 10.00
ROCE(%) 14.67
Trade Value ( ₹ in Lacs) 617.06
Market Cap (₹ in Mn) 0.11
Dividend Yield(%) 0.18
Price/Earning (TTM) 75.56
TTM EPS (₹) 14.82
P/E Ratio 99.10
Book Value(₹) 10.14
PAT Margin (%) 15.31
Face Value (₹) 10.00
ROCE(%) 14.67

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 26636.0 6587.0
Expenses N/A N/A
PBT 9467.2 2272.3
Operating profit 0.0 0.0
Net profit 7010.7 1773.9

Shareholding Pattern

Promoters (% Holding)

23.71%

Mutual funds (% Holding)

16.30%

Non-Institution (% Holding)

4.57%

FI/Banks/Insurance (% Holding)

6.44%

Government (% Holding)

0.00%

FII

45.39%

About Max Healthcare Institute Ltd.

Founded 2001
Managing Director Abhay Soi
NSE Symbol MAXHEALTH

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,56,593.44 1,885.00 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,79,736.83 6,783.95 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,64,289.88 4,885.40 3,295.30 - 3,295.30
Apollo Hospitals Enterprise Ltd. 1,27,019.37 8,781.50 6,696.50 - 6,696.50
Cipla Ltd. 1,17,327.41 1,452.65 1,165.70 - 1,165.70
Zydus Lifesciences Ltd. 1,15,002.22 1,166.55 835.50 - 835.50
Lupin Ltd. 1,13,844.04 2,486.15 1,836.80 - 1,836.80
Dr. Reddy's Laboratories Ltd. 1,12,994.24 1,351.00 1,148.40 - 1,148.40
Max Healthcare Institute Ltd. 1,08,987.16 1,095.10 903.00 - 903.00
Mankind Pharma Ltd. 1,04,549.93 2,513.40 1,909.70 - 1,909.70
no-content No Records Found

Latest News

Jun
20
2026
EQUITY Posted on Jun 20th 2026

Max Healthcare Institute informs about AGM & record date

Max Healthcare Institute has informed about the following with respect to Annual General Meeting, Record Date and Communication sent to members for deduction of tax at source on final dividend: 1) Annual General Meeting: The Twenty-Fifth Annual General Meeting (‘AGM’) of members of the Company is scheduled to be held on Thursday, July 30, 2026 through video conference / other audio-visual means, in accordance with the applicable circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India (‘SEBI’). 2) Record Date: Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed Friday, July 3, 2026, as the ‘Record Date’ for determining the members entitled to receive the final dividend for the financial year 2025-26, if approved by members at the ensuing 25th AGM. 3) Communication to member for deduction of tax at source on final dividend: The Company has today, June 19, 2026, sent a detailed communication to all members of the Company, whose e-mail addresses are registered with the Company/ depositories, indicating the process and documentation required for claiming exemption from deduction of tax at source on final dividend for the financial year 2025-26, which is subject to the approval of members at the ensuing 25th AGM. A copy of e-mail communication sent to members is enclosed as Annexure. This disclosure will also be hosted on Company's website: www.maxhealthcare.in.
The above information is a part of company’s filings submitted to BSE.
Read More
May
20
2026
EQUITY Posted on May 20th 2026

Max Healthcare Institute informs about grant of stock options

Max Healthcare Institute has informed that Nomination and Remuneration Committee (NRC) of the Company in its meeting held today i.e. May 20, 2026, has approved the grant of 2,15,000 stock options to eligible employees under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022. Details pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure. The NRC meeting commenced at 12.15 pm (IST) and concluded at 1.00 pm (IST). This disclosure will also be hosted on Company's website viz. www.maxhealthcare.in.
The above information is a part of company’s filings submitted to BSE.
Read More
May
2
2026
EQUITY Posted on May 2nd 2026

Max Healthcare Institute informs about allotment of equity shares

Max Healthcare Institute has informed that Nomination & Remuneration Committee (‘NRC’) of the Company on May 1, 2026, at 6.56 pm (IST), has approved the allotment of 51,287 equity shares having face value of ₹10 each, fully paid-up, to eligible employees, consequent to the exercise of vested stock options in accordance with Max Healthcare Institute Limited - Employee Stock Option Scheme 2022. Consequent to the above allotment, the paid-up equity share capital of the Company stands increased from 973,19,25,020 to 973,24,37,890. In terms of regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, the requisite details of equity shares allotted as above are enclosed as Annexure. This disclosure will also be hosted on Company's website: www.maxhealthcare.in.

The above information is a part of company’s filings submitted to BSE.

Read More
Jul
8
2026
EQUITY Posted on Jul 8th 2026

JB Chemicals & Pharmaceuticals informs about amalgamation updates

In furtherance to earlier intimations dated 6th July, 2026 and 7th July, 2026 in connection with Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals (Transferor Company) with Torrent Pharmaceuticals (Transferee Company) and their respective shareholders (Scheme), as approved and sanctioned by the Hon’ble National Company Law Tribunal, Ahmedabad Bench (NCLT) vide its order dated 6th July, 2026 (Order). The certified copy of the order was received on 7th July, 2026; JB Chemicals & Pharmaceuticals has informed that Torrent Pharma and JB Chemicals have today, i.e. 8th July, 2026, filed the certified copies of the Order and the Scheme with the Registrar of Companies, Ahmedabad, Ministry of Corporate Affairs, Government of India. Accordingly, the Scheme has become effective today i.e., 8th July, 2026 (Effective Date) and consequently JB Chemicals stands amalgamated into and with Torrent Pharma and dissolved without being wound up. In accordance with the Scheme the Appointed Date is 21st January, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
8
2026
EQUITY Posted on Jul 8th 2026

Amrutanjan Health Care informs about certificate

Pursuant to Regulation 74 (5) of the SEBI (Depository Participants) Regulation, 2018, Amrutanjan Health Care has submitted the certificate issued by its Registrar and Share Transfer Agents Cameo Corporate Services for the quarter ended 30/06/2026.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Max Healthcare Institute Ltd. ?

The current share price of Max Healthcare Institute Ltd. is ₹1,095.90 as of 2026-07-08.

The market capitalisation of Max Healthcare Institute Ltd. is ₹108,987.16 as of 2026-07-07.

The 1-year return of Max Healthcare Institute Ltd. is -203.70% as of 2026-07-08.

The P/E ratio of Max Healthcare Institute Ltd. is 99.10 as of 2026-07-08.

The 52-week high and low of Max Healthcare Institute Ltd. are ₹1,310.80 and ₹903.00, respectively, as of 2026-07-08.

The dividend yield of Max Healthcare Institute Ltd. is 0.1786% as of2026-07-07.

You can buy Max Healthcare Institute Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Max Healthcare Institute Ltd. is Abhay Soi.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore